Latest in News & Research

Skin Cancer Risk Reduced for Patients Treated With Nicotinamide

Greatest effect was seen when nicotinamide was initiated after the first skin cancer

By Elana Gotkine (HealthDay News) | | September 25, 2025

Tool With 14 Predictors Improves Prediction of Invasive Melanoma

Best-fitting model includes 14 predictors and two statistical terms, yielding discriminatory accuracy of 0.74

By Dermsquared Editorial Team | | September 25, 2025

Eczema Recurrence Rate of 23.4 Percent Reported After Discontinuing Dupilumab

Predictors with significant effect on recurrence include allergic conjunctivitis, duration of treatment <16 weeks, male sex

By Dermsquared Editorial Team | | September 25, 2025

Poor Cardiovascular-Kidney-Metabolic Health Increases Psoriasis Risk

Significantly higher risk for psoriasis noted, especially among those with high genetic risk

By Elana Gotkine (HealthDay News) | | September 25, 2025

Image-Based System Reliable for Evaluating Vitiligo Lesions

UV-image Target-VASIs demonstrated strong correlations with tracing paper and clinician Target-VASIs

By Dermsquared Editorial Team | | September 17, 2025

CNN Model Performs Similarly to Dermatologists for Differentiating cSCCs

CNN model yielded area under the curve of 0.69 compared with 0.70 for combined dermatologists' assessment

By Dermsquared Editorial Team | | September 17, 2025

Suicidal Ideation Risk Elevated for Patients With Atopic Eczema

Key predictors of suicidal ideation included younger age and obesity, as well as pruritus, skin pain, symptom intensity

By Elana Gotkine (HealthDay News) | | September 17, 2025

DermaRite Widens Recall to 32 Products Over Bacteria Risk

Recalled items include body washes, lotions, soaps, shampoos, sanitizers and wound cleansers sold nationwide and in Puerto Rico

By India Edwards (HealthDay News) | | September 17, 2025

Diagnostic Excisional Biopsies With Clear Margins Sufficient for Melanoma in Situ

In study, only one local recurrence seen in patient with involved margins at the excisional biopsy who did not undergo wide excision

By Dermsquared Editorial Team | | September 09, 2025

Holistic Approach Recommended for Rosacea in Pregnancy

Patients face emotional distress and their babies may have physical harm from treatment

By Dermsquared Editorial Team | | September 09, 2025

DermaRite Expands Recall of Creams and Sanitizers Over Infection Risk

Products may be contaminated with bacteria that can cause serious infections

By India Edwards (HealthDay News) | | September 09, 2025

High Clearance of Superficial BCC Seen With Photodynamic Therapy With 10% 5-Aminolevulinic Acid Gel

Histologic and clinical clearance higher with photodynamic therapy with 10 percent ALA gel versus vehicle

By Dermsquared Editorial Team | | September 03, 2025

Global Prevalence of Hidradenitis Suppurativa Estimated at 0.99 Percent

Female sex was the only factor associated with prevalence estimates

By Dermsquared Editorial Team | | September 03, 2025

N-NAIL Score More Accurate Than NAPSI for Diagnosing Nail Psoriasis

Both NAPSI and N-NAIL provide accurate cutoffs, but better accuracy seen with N-NAIL, with cutoff value of 2

By Elana Gotkine (HealthDay News) | | September 03, 2025

Metabolic Syndrome, Circadian Syndrome Linked to Melanoma Risk

Stronger associations seen in men; risk for melanoma increases sharply when more than two components of MetS present in men

By Dermsquared Editorial Team | | August 26, 2025

Risk for Serious Infection Up With Adalimumab Use in Hidradenitis Suppurativa Versus Psoriasis

Patients with hidradenitis suppurativa have increased likelihood of sepsis, genitourinary infection versus those with psoriasis

By Dermsquared Editorial Team | | August 26, 2025

High Response to PD-1 Therapy Seen in Unresectable Desmoplastic Melanoma

Complete response rate was 37 percent, and post-hoc end point of objective response rate was 89 percent

By Elana Gotkine (HealthDay News) | | August 26, 2025

Potential Benefits Seen for GLP-1 RAs in Hidradenitis Suppurativa Management

At six months, 50 to 60 percent of patients achieved a 1-point or higher reduction in HS Physician's Global Assessment

By Dermsquared Editorial Team | | August 20, 2025

Patients With Obesity More Likely to Be Diagnosed With Earlier-Stage Melanoma

Individuals with obesity and serious comorbidities significantly more likely to have earlier T-stage at diagnosis

By Dermsquared Editorial Team | | August 20, 2025

Lebrikizumab Efficacious, Safe for Patients With Skin of Color, Eczema

64.4 percent of patients with postinflammatory hyperpigmented lesions at baseline experienced reduced hyperpigmentation at week 24

By Elana Gotkine (HealthDay News) | | August 20, 2025

Public Believes Dermatologic Side Effects From Cancer Treatment Are Common

Findings seen among both those previously treated for cancer and cancer-naive people

By Lori Solomon (HealthDay News) | | August 20, 2025

Firefighters Face Elevated Mortality Rates for Skin and Kidney Cancer

Suggestive increases for prostate and colorectal cancer mortality observed with more years as a firefighter

By Dermsquared Editorial Team | | August 11, 2025

Researchers Identify Risk Thresholds Using 40-GEP to Manage Decisions for cSCC

40-gene expression profiling can inform adjuvant radiation therapy and surveillance imaging decision-making

By Elana Gotkine (HealthDay News) | | August 11, 2025

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026